LyGenesis
VerifiedA clinical-stage cell therapy company that transforms a patient's lymph nodes into bioreactors capable of growing functioning ectopic organs.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$76—114m (Dealroom.co estimates Oct 2023.)
Pittsburgh Pennsylvania (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor investor | $0.0 | round | |
* | $19.0m | Series A | |
| Total Funding | 000k | ||
RELATED LANDSCAPES AND LISTS
Related Content
Recent News about LyGenesis
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.